Chang Tu-Yung, Chien Yen-Wei, Chen Szu-Hua, Sokolow Annelise, Wang Yeh, Wang Brant G, Numan Tricia, Chui M Herman, Stone Rebecca, Pisanic Thomas, Papadopoulos Nicholas, Wang Tian-Li, Douville Christopher, Cope Leslie, Shih Ie-Ming
Department of Gynecology and Obstetrics, Gynecology and Obstetrics, Johns Hopkins Medical Institutions, Baltimore, Maryland.
Department of Pathology, Johns Hopkins Medical Institutions, Baltimore, Maryland.
bioRxiv. 2025 Jun 27:2025.06.24.661327. doi: 10.1101/2025.06.24.661327.
Studying precancerous lesions is essential for improving early detection and prevention, particularly in aggressive cancers such as ovarian carcinoma. Here, we conducted integrated and spatial analyses of transcriptomes, aneuploidy, and clinic-pathological features in 166 ovarian precancerous lesions. Four pre-cancerous subtypes were identified transcriptomically: proliferative, immunoreactive, dormant, and mixed. These subtypes varied in their frequency of germline- mutations, aneuploidy, / amplification, proliferative activity, immune-regulatory gene expression, and histological features. Notably, the immunoreactive subtype upregulated immune-regulatory genes, exhibited chronic inflammation, and was enriched in cases with germline- mutations, deletions of chromosomes 17 (harboring and and 13 (harboring ), leading to a double "two-hit" involving and . Tumor invasion was associated with the activation of interferon response pathways, epithelial-mesenchymal transition, and extracellular matrix remodeling. In summary, our results elucidate the earliest molecular landscape of ovarian precancerous lesions, serving as the foundation for future risk stratification to identify aggressive pre-cancerous lesions.
研究癌前病变对于改善早期检测和预防至关重要,尤其是在卵巢癌等侵袭性癌症中。在此,我们对166例卵巢癌前病变的转录组、非整倍体和临床病理特征进行了综合和空间分析。通过转录组学鉴定出四种癌前亚型:增殖型、免疫反应型、休眠型和混合型。这些亚型在种系突变频率、非整倍体/扩增、增殖活性、免疫调节基因表达和组织学特征方面存在差异。值得注意的是,免疫反应型亚型上调免疫调节基因,表现出慢性炎症,并且在种系突变、17号染色体(包含 和 )和13号染色体(包含 )缺失的病例中富集,导致涉及 和 的双重“双打击”。肿瘤侵袭与干扰素反应途径的激活、上皮-间质转化和细胞外基质重塑有关。总之,我们的结果阐明了卵巢癌前病变最早的分子格局,为未来进行风险分层以识别侵袭性癌前病变奠定了基础。